NEW YORK(GenomeWeb) – Cynvenio Biosystems today announced that its laboratory has received accreditation from theCollegeofAmerican Pathologists. 

The Los Angeles-based molecular diagnostics firm said that the US federal government recognizes the CAP accreditation program as being equal to or more stringent than its own inspection program. During the accreditation process, inspectors examine the lab's records and quality control procedures for the preceding two years, as well as staff qualifications, equipment, facilities, safety program and record, and overall management. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.